Login
$CABA
$1.12 +$0.01 (0.9%) After hours

$CABA SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
16 Nov 2026 SCHEDULE 13G/A
12 Nov 2026 SCHEDULE 13G/A
09 Nov 2026 8-K: Regulation FD Disclosure; Other Events

Disclaimer This presentation, including any printed or electronic copy of these slides, the talks given by the presenters, the information communicated during any delivery of the presentation and any question and answer session and any d...

06 Nov 2026 SCHEDULE 13G/A
06 Nov 2026 SCHEDULE 13G/A
05 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition

RESET-Myositis® registrational adult topline results anticipated in 2H27 with BLA submission in 1Q28, including Phase 1/2 juvenile dermatomyositis data for potential PRV eligibility and Phase 1/2 adult durability data

30 Oct 2026 SCHEDULE 13G/A
27 Oct 2026 SCHEDULE 13G/A
14 Sep 2026 8-K: Other Events

In connection with Cabaletta Bio’s (the “Corporation”) June 2025 underwritten public offering, the Corporation issued 53,090,190 common stock warrants (the “Common Stock Warrants”) that had an exercise price of $2.50 per whole share of i...

14 Aug 2026 SCHEDULE 13G/A
14 Aug 2026 SCHEDULE 13G/A
14 Aug 2026 SCHEDULE 13G/A
13 Aug 2026 10-Q
13 Aug 2026 8-K: Results of Operations and Financial Condition

Registrational RESET-Myositis® clinical data on track to be reported in mid-2027 to support 2H27 BLA submission for rese-cel

12 Aug 2026 SCHEDULE 13G/A
12 Aug 2026 SCHEDULE 13G
31 Jul 2026 SCHEDULE 13G
27 Jul 2026 SCHEDULE 13G

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support